Company Registration No. 12522745 (England and Wales)
ORAAPHARMA LTD
Unaudited accounts
for the year ended 31 December 2024
ORAAPHARMA LTD
Unaudited accounts
Contents
ORAAPHARMA LTD
Company Information
for the year ended 31 December 2024
Director
Mr Ayman Abdelrazek Marwan Dawaba
Company Number
12522745 (England and Wales)
Registered Office
UNIT H LUTON UNIT H ABBEYGATE BUSINESS C
HITCHIN ROAD
LUTON
BEDFORDSHIRE
LU2 0ER
ENGLAND
Accountants
Fabaci Financial Ltd
30 Ebbett Court
Victoria Road
London
W3 6BW
ORAAPHARMA LTD
Statement of financial position
as at 31 December 2024
Tangible assets
8,154
11,581
Cash at bank and in hand
15,617
4,969
Creditors: amounts falling due within one year
(356,852)
(247,933)
Net current liabilities
(326,941)
(228,232)
Net liabilities
(318,787)
(216,651)
Called up share capital
100
100
Profit and loss account
(318,887)
(216,751)
Shareholders' funds
(318,787)
(216,651)
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 29 December 2025 and were signed on its behalf by
Mr Ayman Abdelrazek Marwan Dawaba
Director
Company Registration No. 12522745
ORAAPHARMA LTD
Notes to the Accounts
for the year ended 31 December 2024
ORAAPHARMA LTD is a private company, limited by shares, registered in England and Wales, registration number 12522745. The registered office is UNIT H LUTON UNIT H ABBEYGATE BUSINESS C, HITCHIN ROAD, LUTON, BEDFORDSHIRE, LU2 0ER, ENGLAND.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in GBP sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% Straight Line
Fixtures & fittings
20% Straight Line
Computer equipment
20% Straight Line
Deferred tax arises as a result of including items of income and expenditure in taxation computations in periods different from those in which they are included in the company's accounts. Deferred tax is provided in full on timing differences which result in an obligation to pay more (or less) tax at a future date, at the average tax rates that are expected to apply when the timing differences reverse, based on current tax rates and laws.
Deferred tax assets and liabilities are not discounted.
Basic financial instruments are recognised at amortised cost, except for investments in non-convertible preference and non-puttable ordinary shares which are measured at fair value, with changes recognised in profit or loss. Derivative financial instruments are initially recorded at cost and thereafter at fair value with changes recognised in profit or loss.
Monetary assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rates of exchange ruling at the date of the transaction. Exchange differences are taken into account in arriving at the operating profit.
ORAAPHARMA LTD
Notes to the Accounts
for the year ended 31 December 2024
4
Tangible fixed assets
Plant & machinery
Fixtures & fittings
Computer equipment
Total
Cost or valuation
At cost
At cost
At cost
At 1 January 2024
1,607
11,787
3,744
17,138
At 31 December 2024
1,607
11,787
3,744
17,138
At 1 January 2024
561
4,125
871
5,557
Charge for the year
321
2,357
749
3,427
At 31 December 2024
882
6,482
1,620
8,984
At 31 December 2024
725
5,305
2,124
8,154
At 31 December 2023
1,046
7,662
2,873
11,581
Amounts falling due within one year
Accrued income and prepayments
11,137
11,184
6
Creditors: amounts falling due within one year
2024
2023
Trade creditors
20,018
2,746
Taxes and social security
1,193
(28)
Loans from directors
333,287
242,915
Allotted, called up and fully paid:
100 Ordinary shares of £1 each
100
100
8
Average number of employees
During the year the average number of employees was 5 (2023: 3).